Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

NAActive, not recruitingINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
AphakiaAstigmatismPresbyopia
Interventions
DEVICE

Clareon Vivity IOL - Non Toric

Spherical extended vision IOL implanted in the capsular bag of the eye for the visual correction of aphakia in adult patients with less than 1.00 diopter of preoperative corneal astigmatism in whom a cataractous lens has been removed.

DEVICE

Clareon Vivity IOL - Toric

Toric extended vision IOL implanted in the capsular bag of the eye for the visual correction of aphakia and for reduction of residual refractive astigmatism in adult patients in whom a cataractous lens has been removed.

DEVICE

Clareon PanOptix Trifocal IOL - Non Toric

Spherical trifocal IOL implanted in the capsular bag of the eye for the visual correction of aphakia in adult patients with less than 1.00 diopter of preoperative corneal astigmatism in whom a cataractous lens has been removed.

DEVICE

Clareon PanOptix Trifocal IOL - Toric

Toric trifocal IOL implanted in the capsular bag of the eye for the visual correction of aphakia and for reduction of residual refractive astigmatism in adult patients in whom a cataractous lens has been removed.

Trial Locations (7)

13088

Eye Surgeons of CNY, Liverpool

32204

Levenson Eye Associates, Jacksonville

74104

Tulsa Ophthalmology, Tulsa

76107

Chu Eye Institute, Fort Worth

84107

The Eye Institute of Utah, Salt Lake City

90505

Wolstan & Goldberg Eye Associates, Torrance

00921

Centro Oftalmologico Metropolitano, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY